Periodic Reporting for period 1 - HealMastitis (Heal Mastitis in Dairy Cattle)
Período documentado: 2017-12-01 hasta 2018-05-31
Our technology will be an important tool to keep the society safe and healthy by keeping the milk free from antibiotics. Consumers will feel safer and will lead a healthier life. It is also important to provide the dairy industry an innovative technology to prevent Mastitis in order to supply good quality milk to the people.
We have developed a technology to treat the mastitis disease in dairy cattle without any antibiotics. Our system communicates with the farm computer, receives the energetic signature of the mastitis pathogens of the cattle in the farm and processes the cows’ drinking water according to the information received from a microbiological laboratory. During this feasibility study, we would like to analyse the market and consolidate the business plan.
• Revision of technical design of the system to reduce manufacturing cost
• Product supply chain identification
• Communication with major diary industry in Germany, the Netherlands, The UK, Ireland, France and Israel
• Market analysis that includes size, growth and trend of niche market for the PRISE. The market opportunity of our product and necessary strategies have been studied.
• Competitor analysis.
• Technical, environmental, management and commercial risks have been investigated.
• Strength, Weakness, Opportunities and Threats (SWOT) and Porter’s five forces analysis.
• Financial plan for next five years were done
• IPR management plan have been formulated
• Consolidated business plan.
The main results of our activities:
• The entire system was evaluated and it is optimized to reduce the cost by ca. 25%
• We communicated with several dairy industries in the Europe and could established preliminary contacts to validate our system during the planned phase 2 project.
• We have strengthen our supply chain.
• We have identified our niche market, its size, growth and trends.
• The potential risks of our product are identified and we have developed necessary measures to overcome the potential risks.
• We consulted with an IPR attorney to verify the chance of patent application of our system. The positive analysis will allow us to apply for the patent soon.